Engineering the
Language of Life
Therapeutics
AI-driven suppressor tRNA therapeutics for rare genetic diseases caused by premature termination codons
Our Guiding Principles
Three core values that drive every aspect of our therapeutic development
Patient-First
Every decision prioritizes patient outcomes and accessibility
Programmable Biology
Engineering cellular translation with precision and control
Safety by Design
Built-in safeguards at every level of therapeutic development
Ready to Transform Rare Disease Treatment?
Join us in developing the next generation of genetic medicines